ORY-1001
CAS: 1431326-61-2
Ref. 3D-GHC32661
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Información del producto
Ory-1001 is a monoclonal antibody that binds to the HL-60 leukemia cell surface protein CD22, which is a receptor for the B-cell growth factor. Ory-1001 inhibits the binding of this growth factor to its receptor, thereby inhibiting cell proliferation and migration. Ory-1001 has been shown to eradicate leukemic stem cells in vivo and inhibit tumor growth in vitro. The drug has also been shown to have cardioprotective properties, likely due to its ability to inhibit the production of cardiac growth factors.
Propiedades químicas
Consulta técnica sobre: 3D-GHC32661 ORY-1001
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.